Literature DB >> 27888598

Adult Onset Still's Disease With Different Antibodies: A Case Report and Review of Literature.

Maryam Mobini1, Roya Ghasemian2, Fatemeh Zameni2.   

Abstract

Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown etiology. There is not currently any specific serological markers for AOSD , and  diagnosis still relying on the exclusion of other likely diagnoses. Yamaguchi's criteria are used as a diagnostic criterion which contains negative serologic markers for other collagen vascular diseases including systemic lupus erythematosus and rheumatoid arthritis. Here we report a 28-year-old woman with arthralgia, fever, rash, leukocytosis, lymphadenopathy, sore throat, abnormal liver function and negative rheumatoid factor and ANA but  seropositive for anti-CCP, anti-dsDNA, and C-ANCA. It seems that despite AOSD is considered as a seronegativedisorder; it should be remembered in patients with compatible findings who are seropositive.

Entities:  

Keywords:  ANCA; Adult-onset Still’s disease; Anti CCP; Anti-dsDNA; Polyarthralgia

Mesh:

Substances:

Year:  2016        PMID: 27888598

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  3 in total

Review 1.  Sjögren's syndrome with adult-onset Still's disease: an overlap syndrome?

Authors:  Pingyang Han; Chen Sun; Yinghong Zhang; Juzhen Yan
Journal:  Rheumatol Int       Date:  2021-05-20       Impact factor: 2.631

2.  Acute appendicitis complicated with necrotizing fasciitis in a patient with adult-onset Still's disease: A case report.

Authors:  Zheng-Hao Huang; Yu-Chen Chiu; Li-Lu Ho; Hsiu-Lung Fan; Chun-Chi Lu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

3.  Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.

Authors:  Yasuaki Hirooka; Saki Okuda; Masafumi Sugiyama; Toshihiko Shiga; Yuji Nozaki; Koji Kinoshita; Masanori Funauchi; Itaru Matsumura
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.